Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2014
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785696A1 Novel compounds
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/08/2014EP2785694A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/08/2014EP2785693A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
10/08/2014EP2785692A1 Substituted anilines as ccr(4) antagonists
10/08/2014EP2785690A1 Piperidine derivatives, pharmaceutical compositions and uses thereof
10/07/2014US8853427 Neprilysin inhibitors
10/07/2014US8853420 Compounds
10/07/2014US8853418 Cyclopentylpyrazoles as N-type calcium channel blockers
10/07/2014US8853414 Process for producing pyripyropene derivatives
10/07/2014US8853413 Process for producing pyripyropene derivatives
10/07/2014US8853412 Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
10/07/2014US8853411 Process for the preparation of dexlansoprazole
10/07/2014US8853408 Cyclopropylamines as LSD1 inhibitors
10/07/2014US8853406 Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853392 Benzamide mGluR5 positive allosteric modulators and methods of making and using same
10/07/2014US8853391 Tricyclic azaindoles
10/07/2014US8853390 Processes for preparing 1,2-substituted cyclopropyl derivatives
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853245 Orally bioavailable dabigatran prodrugs for the treatment of diseases
10/07/2014US8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
10/07/2014US8853242 Nitrogenous-ring acylguanidine derivative
10/07/2014US8853230 Inhibitors of JAK
10/07/2014US8853225 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
10/07/2014US8853218 Compounds
10/07/2014US8853205 Heteropyrrole analogs acting on cannabinoid receptors
10/07/2014US8853202 Modulators of CXCR7
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/07/2014US8852759 Compound having acridan ring structure, and organic electroluminescent device
10/07/2014US8852554 Radiolabelled PDE10 ligands
10/02/2014WO2014160810A1 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
10/02/2014WO2014160707A1 Wavelength conversion films with multiple photostable organic chromophores
10/02/2014WO2014160692A1 2-keto amide derivatives as hiv attachment inhibitors
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014160649A1 Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
10/02/2014WO2014160592A2 FACTOR XIa INHIBITORS
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160430A1 Small molecule lrrk2 and erk5 inhibitors
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014160181A1 Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders
10/02/2014WO2014160177A2 Quinazoline inhibitors of pi3k
10/02/2014WO2014160143A2 Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
10/02/2014WO2014160031A1 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
10/02/2014WO2014160017A1 Pyridine cdk9 kinase inhibitors
10/02/2014WO2014159993A1 Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis
10/02/2014WO2014158916A1 Substituted naphthyridine and quinoline compounds as mao inhibitors
10/02/2014WO2014158045A1 Dimeric quaternary pyridinium salts possessing biocidal activity
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157687A1 1,2,4-triazine-6-carboxamide derivative with acetamide group
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014154921A1 Method for the synthesis of homologous compounds of azanucleosides
10/02/2014WO2014154829A1 Herbicidal compounds
10/02/2014WO2014154807A1 Process for preparing sulfimines and their in-situ conversion into n-(2-amino-benzoyl)-sulfimines
10/02/2014WO2014154794A1 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
10/02/2014WO2014154723A1 Novel pyrrole derivatives for the treatment of cancer
10/02/2014WO2014154682A1 Novel viral replication inhibitors
10/02/2014WO2014154586A1 Pyrazolonaphthyridinone derivatives as metap2 inhibitors (methionine aminopeptidase type-2)
10/02/2014WO2014154173A1 Anti-angiogenic compound
10/02/2014WO2014154168A1 Bicyclic substituted pyrimidine pde-5 inhibitor prodrug
10/02/2014WO2014153624A1 Antibacterial compounds
10/02/2014US20140296532 Compositions and methods for the treatment of malaria
10/02/2014US20140296528 4-aryl-1-(biarylmethylene) piperidine compounds
10/02/2014US20140296514 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/02/2014US20140296343 Non-peptide bdnf neurotrophin mimetics
10/02/2014US20140296295 2-alkoxy-substituted dicyanopyridines and their use
10/02/2014US20140296292 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
10/02/2014US20140296291 Novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
10/02/2014US20140296287 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
10/02/2014US20140296286 Compounds with increased specificity for the treatment of glioma
10/02/2014US20140296266 Therapeutic compounds
10/02/2014US20140296252 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities
10/02/2014US20140296238 Dihydropyrazoles
10/02/2014US20140296237 Picolinamide derivatives as ttx-s blockers
10/02/2014US20140296236 Quinolines as fgfr kinase modulators
10/02/2014US20140296235 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296225 Inhibitors of the Renal Outer Medullary Potassium Channel
10/02/2014US20140296224 Quinoline derivatives as pi3 kinase inhibitors
10/02/2014US20140296217 Medicaments for the treatment or prevention of fibrotic diseases
10/02/2014US20140296215 Cyanoquinoline Compounds Having Activity in Correcting Mutant-Cftr Processing and Increasing Ion Transport and Uses Thereof
10/02/2014US20140296214 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
10/02/2014US20140296206 Compositions useful for treating disorders related to kit
10/02/2014US20140296202 Substituted piperidinyl compounds useful as gpr119 agonists
10/02/2014US20140296200 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
10/02/2014US20140296196 Nk1 antagonists
10/02/2014US20140295437 Cyanine compounds and their application as quenching compounds
10/02/2014US20140294767 Method of treating hcv infection with a small molecule chk2 inhibitor
10/02/2014US20140294764 Compounds and compositions used to epigenetically transform cells and methods related thereto
10/01/2014EP2784076A1 Dimeric SMAC mimetics
10/01/2014EP2784075A1 Hepatitis C virus inhibitors
10/01/2014EP2784074A1 Pyrazole compound and use thereof for medical purposes
10/01/2014EP2784073A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784072A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784071A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2784070A1 3-phenyl-4-pyri(mi)dinyl-1h-pyrazoles and their use as fungicides
10/01/2014EP2782911A1 Process for the preparation of gamma amino acids and intermediates used in said process
10/01/2014EP2782910A1 Process for preparing n-substituted 1h-pyrazole-5-carboxylate compounds and derivatives thereof
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 1080